We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
+17.12%
1 Year Est. Return
+35.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$72M
AUM Growth
-$2.02M
Cap. Flow
-$13.2M
Cap. Flow %
-18.39%
Top 10 Hldgs %
55.78%
Holding
74
New
10
Increased
7
Reduced
41
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 17.15%
2 Financials 15.01%
3 Communication Services 14.08%
4 Technology 12.22%
5 Consumer Discretionary 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPMC
26
DELISTED
Blueprint Medicines
BPMC
$693K 0.96%
8,662
-9,866
-53% -$729K
PCG icon
27
PG&E
PCG
$38.5B
$668K 0.93%
+37,500
New +$606K
AUPH icon
28
Aurinia Pharmaceuticals
AUPH
$2.11B
$631K 0.88%
97,056
-20,000
-17% -$133K
GWPH
29
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$586K 0.81%
3,479
-334
-9% -$49.7K
NS
30
DELISTED
NuStar Energy L.P.
NS
$552K 0.77%
20,520
-17,927
-47% -$464K
DB icon
31
Deutsche Bank
DB
$71.5B
$512K 0.71%
63,000
-15,908
-20% -$139K
BLUE
32
DELISTED
bluebird bio
BLUE
$500K 0.69%
245
-56
-19% -$98.6K
ZGNX
33
DELISTED
Zogenix, Inc.
ZGNX
$479K 0.67%
8,704
-3,000
-26% -$143K
VWO icon
34
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$403K 0.56%
9,480
SLV icon
35
iShares Silver Trust
SLV
$30.9B
$398K 0.55%
28,094
-19,133
-41% -$279K
CCS icon
36
Century Communities
CCS
$2.03B
$396K 0.55%
16,517
-3,644
-18% -$82.9K
IBB icon
37
iShares Biotechnology ETF
IBB
$9.71B
$365K 0.51%
3,265
-457
-12% -$50.1K
V icon
38
Visa
V
$677B
$336K 0.47%
2,149
-301
-12% -$43.4K
TERP
39
DELISTED
TerraForm Power, Inc
TERP
$311K 0.43%
+22,599
New +$278K
BCS icon
40
Barclays
BCS
$94.1B
$303K 0.42%
38,721
-5,920
-13% -$47.6K
WMB icon
41
Williams Companies
WMB
$86.1B
$302K 0.42%
10,517
-450
-4% -$12.1K
AMRN
42
Amarin Corp
AMRN
$303M
$300K 0.42%
722
-1,229
-63% -$443K
GM.WS.B
43
DELISTED
General Motors Company
GM.WS.B
$280K 0.39%
14,403
CELG
44
DELISTED
Celgene Corp
CELG
$272K 0.38%
+2,887
New +$252K
PBYI icon
45
Puma Biotechnology
PBYI
$454M
$270K 0.38%
+6,962
New +$213K
BMRN icon
46
BioMarin Pharmaceuticals
BMRN
$12.4B
$258K 0.36%
2,902
-1,000
-26% -$92.7K
NBIS
47
Nebius Group N.V.
NBIS
$47.7B
$251K 0.35%
7,310
-70
-0.9% -$2.32K
GDX icon
48
VanEck Gold Miners ETF
GDX
$27.4B
$226K 0.31%
10,087
-240
-2% -$5.28K
XOP icon
49
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.43B
$205K 0.28%
1,665
-232
-12% -$27.9K
NETI
50
DELISTED
Eneti Inc.
NETI
$198K 0.28%
5,560
-137
-2% -$5.98K

Similar funds

Kazazian Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Kazazian Asset Management held 74 positions worth $72M, down 2.7% from $74M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Kazazian Asset Management withdrew a net $13.2M in Q1 2019, closing 11 positions and reducing 41 holdings. Its most notable exit was Abbott, an estimated $662K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 21% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Kazazian Asset Management opened a new position in Cloudera, Inc. worth $1.06M.

  • Kazazian Asset Management's largest Q1 2019 buy was Cloudera, Inc.: 96,748 shares worth $1.06M.
  • Kazazian Asset Management added most to Baidu in Q1 2019, an estimated $1.84M increase.
  • Kazazian Asset Management's biggest Q1 2019 reduction was Goldman Sachs, cutting an estimated $4.46M.
  • Kazazian Asset Management fully exited Abbott in Q1 2019, selling an estimated $662K.
  • Kazazian Asset Management's ten largest holdings make up 56% of its $72M portfolio in Q1 2019.
  • Kazazian Asset Management opened 10 new positions and closed 11 in Q1 2019.
  • Kazazian Asset Management's portfolio value fell 2.7% quarter-over-quarter to $72M.

Based on Kazazian Asset Management's 13F filing for Q1 2019, filed 15 May 2019.